|
| Press Releases |
|
 |
|
| Tuesday, June 25, 2019 |
|
|
Jacobson Pharma Announces FY2019 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2019 (the "FY2019"). more info >> |
|
| Wednesday, May 8, 2019 |
|
|
雅各臣与云南白药集团将继续探讨业务及其他方面合作可行性 |
| 从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─ 雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）获其股东云南白药控股有限公司（「白药控股」）及云南白药集团股份有限公司（「云南白药集团」，于深圳证券交易所上市）告知，云南白药集团将与白药控股进行吸收合并重组。 more info >> |
|
|
雅各臣與雲南白藥集團將繼續探討業務及其他方面合作可行性 |
| 從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）獲其股東雲南白藥控股有限公司（「白藥控股」）及雲南白藥集團股份有限公司（「雲南白藥集團」，於深圳證券交易所上市）告知，雲南白藥集團將與白藥控股進行吸收合併重組。 more info >> |
|
|
Jacobson Pharma and Yunnan Baiyao Group to Continue Exploring Further Possibilities of Business Cooperation and Other Collaborations |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has been informed by Yunnan Baiyao Holdings Company Limited1 ("Baiyao Holdings") and Yunnan Baiyao Group Co.,Ltd. more info >> |
|
| Thursday, May 2, 2019 |
|
|
雅各臣公布盈喜 |
| 从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─ 雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）今天公布盈喜预告，就集团截至二零一九年三月三十一日止财政年度的未经审核综合管理财务报表之初步评估，预期集团之公司股东应占综合溢利较二零一八年三月三十一日止财政年度增加超过20%。 more info >> |
|
|
雅各臣公布盈喜 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）今天公佈盈喜預告，就集團截至二零一九年三月三十一日止財政年度的未經審核綜合管理財務報表之初步評估，預期集團之公司股東應佔綜合溢利較二零一八年三月三十一日止財政年度增加超過20%。
more info >> |
|
|
Jacobson Pharma Issues Positive Profit Alert |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced a positive profit alert. more info >> |
|
| Wednesday, November 21, 2018 |
|
|
雅各臣公布二零一九财年中期业绩 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）今天公布公司及其附属公司（统称「集团」）于截至二零一八年九月三十日止六个月（「报告期」）的未经审核中期业绩。
more info >> |
|
|
雅各臣公佈二零一九財年中期業績 |
| 從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）今天公佈公司及其附屬公司（統稱「集團」）於截至二零一八年九月三十日止六個月（「報告期」）的未經審核中期業績。 more info >> |
|
|
Jacobson Pharma Announces FY2019 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2018 (the "reporting period").
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM
Feb 25, 2026 21:59: JST
|
|
|
Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM
Feb 25, 2026 21:59 JST
|
|
|
雲頂新耀股東特別大會通過商業化服務協議等決議案
Feb 25, 2026 20:59 HKT/SGT
|
|
|
云顶新耀股东特别大会通过商业化服务协议等决议案
Feb 25, 2026 20:59 HKT/SGT
|
|
|
Doubleview Gold Corp. Reports Updated Mineral Resource Estimate as of February 25, 2026 Including a Copper Equivalent Mineral Resource: 609 (Mt) of Measured and Indicated Resources at 0.43% CuEq containing CuEq 5.82 Billion lbs. 503 (Mt) of Inferred Resources at 0.41% CuEq containing CuEq 4.57 Billion lbs
Feb 25, 2026 20:59 HKT/SGT
|
|
|
Toyota Launches New bZ4X Touring BEV Focused on Driving Performance and Spaciousness in Japan
Feb 25, 2026 21:58 JST
|
|
|
DOCOMO and Keio University Demonstrate World's First Stable, High-Fidelity Robot Teleoperation via Commercial 5G Using Low-Latency Slicing
Feb 25, 2026 21:01 JST
|
|
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Feb 25, 2026 19:57 HKT/SGT
|
|
|
DOCOMO Successfully Demonstrates AI Application Operation Using Virtualized Radio Access Network (vRAN) Infrastructure
Feb 25, 2026 20:50 JST
|
|
|
DOCOMO Begins Commercial Deployment of Agentic AI System for Network Maintenance Using One of the World's Largest Datasets
Feb 25, 2026 20:40 JST
|
|
|
Champion REIT Delivers Resilient Performance, Proactive Tenant Mix Optimisation Drives Sustainable Development
Feb 25, 2026 19:30 HKT/SGT
|
|
|
冠君產業信託於挑戰中彰顯韌性 積極優化租戶組合推動持續發展
Feb 25, 2026 19:30 HKT/SGT
|
|
|
周大福人壽支持《財政預算案》有關跨境安老、落實《香港可持續披露準則》以及推動體育普及化、盛事化等措施
Feb 25, 2026 18:07 HKT/SGT
|
|
|
HKTDC welcomes the 2026-27 Budget
Feb 25, 2026 17:29 HKT/SGT
|
|
|
NEC Implements AI Code Review Service "Metabob," Reducing Technical Verification Time by Up to 66%
Feb 25, 2026 18:00 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
